期刊文献+

慢性肝病患者CT血流灌注与肝纤维化血清指标相关性探讨 被引量:1

Evaluation of CT perfusion to liver fibrosis and cirrhosis and the correlation with serum indicator
下载PDF
导出
摘要 目的:探讨肝脏纤维化及早期肝硬化患者CT血流灌注参数与肝纤维化血清指标的相关性。方法:使用GE64层螺旋CT灌注技术计算40例经病理证实不同分期肝纤维化患者及10例正常对照人群肝血流量(blood flow,BF)、肝血容积(blood volume,BV)、肝动脉血流(hepatic arteral fraction,HAF)、平均通过时间(mean transit time,MTT)、表面通透性(permeability surface,PS)等血流动力学参数,同时检测肝纤维化血清学指标:血清Ⅲ型胶原(typeIII,procolla-gen peptide)、透明质酸(hyaluronic,HA)、层粘蛋白(laminin,LN)、Ⅳ型胶原(collagen,CIV),并与病理结果对照。结果:自肝炎到早期肝硬化阶段,S0,S2,S4期的HAF呈升高趋势,BV和BF都升高,MTT缩短,PS降低。在不同时期BV、BF、HAF和MTT的差异有统计学意义。血清学指标HA、LN、胶原IV、胶原III及CT灌注指标BV、BF、MTT、PS、HAF之间,除HA与MTT、PS与LN,MTT与IV型胶原呈负相关,其余各指标间均呈正相关。结论:肝脏血流动力学微循环变化反映了肝纤维化及早期肝硬化的病理过程。 Objective:To evaluate the correlation of hepatic perfusion with multi-slice spiral CT and several serum markers in the diagnosis of liver fibrosis and cirrhosis.Methods:CT perfusion parameters of blood flow(BF),blood volume(BV),hepatic arteral fraction(HAF),mean transit time(MTT),permeability surface(PS) along with the serum fibrosis markers: procollagen peptide(typeIII),hyaluronic(HA),laminin(LN),IV collagen were achieved and compared in different groups proved by pathology.Results:CT perfusion parameters had significant differences in control and different fibrosis groups,BV,BF and HAF were increasing while MTT shorten and PS decrease with fibrosic degree.HA was inverse correlation with MTT and PS with LN,MTT with collagen IV,other perfusion parameters were direct correlation with serum indicators.Conclusion:CT perfusion parameters can reflect the deposition of collogen and the change of microcirculation.
出处 《医学影像学杂志》 2011年第3期360-363,共4页 Journal of Medical Imaging
基金 上海市浦东新区卫生局青年基金(编号:PW2007B-1)
关键词 肝纤维化 灌注 血清诊断 体层摄影术 X线计算机 Liver fibrosis Serum diagnosis Perfusion Tomography X-ray computed
  • 相关文献

参考文献3

二级参考文献5

共引文献103

同被引文献16

  • 1杨大国,王林杰,肖野.慢性肝炎肝纤维化发生率及其相关因素的探讨(附202例分析)[J].临床肝胆病杂志,1995,11(4):200-202. 被引量:12
  • 2刘绍能,陶夏平,王融冰,徐瑞平,刘震,周斌,白宇宁,许德军,付菊萍,刘军民,孙凤霞.慢性乙型肝炎中医病因病机演变规律研究[J].中国中医药信息杂志,2007,14(12):14-16. 被引量:18
  • 3Ismail M H,Pinzani M.Reversal of liver fibrosis.Saudi J Gastroenterol,2009,15(1):72-79.
  • 4Bataller R,Brenner D A.Liver fibrosis.J Clin Invest, 2005,115(4):209-218.
  • 5Li J T,Liao Z X,Ping J.et al.Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies J Gastroenterol, 2008,43(6):419-428.
  • 6McMahon B J.The natural history of chronic hepatitis B virus infection.Semin liver Dis,2004,24(1):17-21.
  • 7Fattovich G,Bortolotti F,Donato F.Natural history of chronic hepatitis Bispecial emphasis ondisease progression and prognostic factors.Hepatology,2008,48(2):335-352.
  • 8Chang T T,Liaw Y F,Wu S S,et al .Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.Hepatology, 2010,52(3):886-893.
  • 9Long H Nguyen,David Chao,Joseph K,et al.Histologic changes in liver tissue from patients with chronic hepatitis B and minimal increases in levels of alanine aminotransferase:A meta-analysis and systematic review.Clinical Gastroenterology and Hepatology, 2014,39(4):349-358.
  • 10李月波,陈建红,董新英,丁洪燕.128例慢性乙型肝炎微循环与肝组织病理关系的相关性研究[J].实用全科医学,2008,6(1):30-31. 被引量:5

引证文献1

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部